Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs KAMRON LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA KAMRON LABORATORIES CIPLA/
KAMRON LABORATORIES
 
P/E (TTM) x 32.4 7.1 454.3% View Chart
P/BV x 4.0 2.7 150.2% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 CIPLA   KAMRON LABORATORIES
EQUITY SHARE DATA
    CIPLA
Mar-22
KAMRON LABORATORIES
Mar-21
CIPLA/
KAMRON LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0836 19,693.6%   
Low Rs8065 16,972.6%   
Sales per share (Unadj.) Rs269.710.8 2,493.7%  
Earnings per share (Unadj.) Rs31.7-2.2 -1,446.5%  
Cash flow per share (Unadj.) Rs44.8-0.4 -10,071.4%  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs257.83.3 7,809.4%  
Shares outstanding (eoy) m806.815.85 13,791.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.50.5 739.2%   
Avg P/E ratio x29.8-2.3 -1,274.5%  
P/CF ratio (eoy) x21.1-11.5 -183.0%  
Price / Book Value ratio x3.71.6 236.0%  
Dividend payout %15.80-   
Avg Mkt Cap Rs m762,17730 2,542,072.9%   
No. of employees `000NANA-   
Total wages/salary Rs m35,29916 225,553.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,63363 343,921.3%  
Other income Rs m3,2170 4,596,142.9%   
Total revenues Rs m220,85163 348,619.9%   
Gross profit Rs m43,298-2 -1,850,359.0%  
Depreciation Rs m10,52010 102,829.9%   
Interest Rs m1,0640 322,272.7%   
Profit before tax Rs m34,933-13 -272,273.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3380-   
Profit after tax Rs m25,595-13 -199,491.0%  
Gross profit margin %19.9-3.7 -538.5%  
Effective tax rate %26.70-   
Net profit margin %11.8-20.3 -58.0%  
BALANCE SHEET DATA
Current assets Rs m147,10820 741,847.2%   
Current liabilities Rs m49,12933 148,920.0%   
Net working cap to sales %45.0-20.8 -216.6%  
Current ratio x3.00.6 498.2%  
Inventory Days Days631 12,124.6%  
Debtors Days Days691,298,359 0.0%  
Net fixed assets Rs m119,41537 327,163.3%   
Share capital Rs m1,61459 2,758.3%   
"Free" reserves Rs m206,364-39 -526,571.8%   
Net worth Rs m207,97719 1,077,043.5%   
Long term debt Rs m4,1620-   
Total assets Rs m266,52356 473,061.6%  
Interest coverage x33.8-37.9 -89.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.1 72.7%   
Return on assets %10.0-22.2 -45.1%  
Return on equity %12.3-66.5 -18.5%  
Return on capital %17.0-64.8 -26.2%  
Exports to sales %26.27.4 352.3%   
Imports to sales %8.20-   
Exports (fob) Rs m57,0945 1,212,193.2%   
Imports (cif) Rs m17,803NA-   
Fx inflow Rs m60,1805 1,277,696.4%   
Fx outflow Rs m17,8030-   
Net fx Rs m42,3765 899,704.9%   
CASH FLOW
From Operations Rs m33,259-3 -1,131,258.5%  
From Investments Rs m-18,7191 -1,599,897.4%  
From Financial Activity Rs m-15,998NA 4,847,848.5%  
Net Cashflow Rs m-1,323-2 63,311.0%  

Share Holding

Indian Promoters % 13.5 30.2 44.7%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.0 0.0 -  
FIIs % 27.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 69.8 95.1%  
Shareholders   418,910 18,689 2,241.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DR. REDDYS LAB    SUN PHARMA    LUPIN    PIRAMAL ENTERPRISES    AUROBINDO PHARMA    



Today's Market

Sensex Reclaims 60,000-Mark, Nifty Tops 17,900; NTPC, Bajaj Finserv & Bajaj Finance Top Gainers(10:30 am)

Asian share markets opened higher today as investors took heart from strong US retail sector reports and worries eased over inflation.